- Home
- LPTX vs INTZ Comparison
LPTX vs INTZ Comparison
Compare LPTX & INTZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- INTZ
- Stock Information
- Founded
- LPTX 2011
- INTZ 1983
- Country
- LPTX United States
- INTZ United States
- Employees
- LPTX N/A
- INTZ N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- INTZ Computer Communications Equipment
- Sector
- LPTX Health Care
- INTZ Telecommunications
- Exchange
- LPTX Nasdaq
- INTZ Nasdaq
- Market Cap
- LPTX 35.4M
- INTZ 37.6M
- IPO Year
- LPTX N/A
- INTZ 2020
- Fundamental
- Price
- LPTX $0.48
- INTZ $1.82
- Analyst Decision
- LPTX Hold
- INTZ Buy
- Analyst Count
- LPTX 1
- INTZ 2
- Target Price
- LPTX N/A
- INTZ $7.00
- AVG Volume (30 Days)
- LPTX 7.7M
- INTZ 291.5K
- Earning Date
- LPTX 11-13-2025
- INTZ 11-11-2025
- Dividend Yield
- LPTX N/A
- INTZ N/A
- EPS Growth
- LPTX N/A
- INTZ N/A
- EPS
- LPTX N/A
- INTZ N/A
- Revenue
- LPTX N/A
- INTZ $6,828,000.00
- Revenue This Year
- LPTX N/A
- INTZ $36.75
- Revenue Next Year
- LPTX N/A
- INTZ $30.90
- P/E Ratio
- LPTX N/A
- INTZ N/A
- Revenue Growth
- LPTX N/A
- INTZ 25.86
- 52 Week Low
- LPTX $0.22
- INTZ $0.35
- 52 Week High
- LPTX $4.79
- INTZ $7.34
- Technical
- Relative Strength Index (RSI)
- LPTX 47.84
- INTZ 48.56
- Support Level
- LPTX $0.43
- INTZ $1.81
- Resistance Level
- LPTX $0.56
- INTZ $2.00
- Average True Range (ATR)
- LPTX 0.06
- INTZ 0.14
- MACD
- LPTX -0.02
- INTZ -0.00
- Stochastic Oscillator
- LPTX 16.04
- INTZ 20.96
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is a biopharmaceutical company developing novel biomarker-targeted antibody therapies designed to treat patients with cancer by inhibiting fundamental tumor-promoting pathways, targeting cancer-specific cell surface molecules, and harnessing the immune system to attack cancer cells. The company's key clinical-stage drug candidate is sirexatamab (DKN-01), which targets Dickkopf-related protein 1 (DKK1) and is being studied in a clinical trial in patients with colorectal cancer. In addition, it also has a preclinical program to develop a proprietary monoclonal antibody, called FL-501 which works by inhibiting the GDF-15 protein.
About INTZ Intrusion Inc.
Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.